ATARA BIOTHERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 507000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-06-30) |
| Status | current |
| Entity | ATARA BIOTHERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:26:12.408733+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6605e6ac-2d64-42a2-905d-eb9258da68bf
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-039820 · Open the official SEC filing →Retrieved: 2026-08-19T16:26:12.408733+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001604464/accounts-receivable/2023-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6605e6ac-2d64-42a2-905d-eb9258da68bf
History
- no predecessors — first report